M&T Bank
CGON icon

M&T Bank’s CG Oncology CGON Stock Holding History

M&T Bank’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$277K Buy
+4,086
New +$232K ﹤0.01% 1407
2025
Q1 		– Sell
-16,891
Closed -$485K – 1575
2024
Q4 		$485K Buy
16,891
+133
+0.8% +$4.55K ﹤0.01% 1179
2024
Q3 		$632K Buy
16,758
+5,996
+56% +$210K ﹤0.01% 1072
2024
Q2 		$340K Buy
10,762
+1,182
+12% +$41K ﹤0.01% 1263
2024
Q1 		$420K Buy
+9,580
New +$391K ﹤0.01% 1200

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

M&T Bank's CGON Position: Q1 2026 in Review

M&T Bank opened a new position in CG Oncology (CGON) in Q1 2026: 4,086 shares worth $277K. The stake represents ﹤0.01% of the portfolio and ranks #1407 among its holdings. This is a return to the name: M&T Bank previously reported a position in CGON as recently as Q4 2024.

M&T Bank first reported a position in CGON in Q1 2024 and has held it in 5 quarters since. The position peaked at $632K in Q3 2024. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • M&T Bank held 4,086 shares of CG Oncology worth $277K as of Q1 2026.
  • CG Oncology was a new M&T Bank position in Q1 2026.
  • CG Oncology made up ﹤0.01% of M&T Bank's portfolio in Q1 2026, its #1407 holding.
  • M&T Bank first reported a position in CG Oncology in Q1 2024 and has held it in 5 quarters since.
  • M&T Bank's CG Oncology position peaked at $632K in Q3 2024.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.